Cambiar Investors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,494
Closed -$211K 171
2017
Q4
$211K Sell
2,494
-471,147
-99% -$40.1M ﹤0.01% 168
2017
Q3
$40.5M Sell
473,641
-60,432
-11% -$4.96M 0.64% 43
2017
Q2
$44M Sell
534,073
-16,477
-3% -$1.34M 0.69% 41
2017
Q1
$46.3M Sell
550,550
-28,081
-5% -$2.25M 0.77% 38
2016
Q4
$42.6M Buy
+578,631
New +$43.1M 0.73% 47

Other funds holding LLY

Cambiar Investors's LLY Position: Q1 2018 in Review

Cambiar Investors sold out of Eli Lilly (LLY) in Q1 2018, closing a stake of 2,494 shares — an estimated $211K sold.

Cambiar Investors first reported a position in LLY in Q4 2016 and held it in 5 quarters. The position peaked at $46.3M in Q1 2017. 1,333 funds tracked by Wall St. Rank hold LLY as of Q1 2018.

  • Cambiar Investors reported no remaining Eli Lilly position as of Q1 2018 after selling out during the quarter.
  • Cambiar Investors sold 2,494 Eli Lilly shares in Q1 2018, an estimated $211K.
  • Cambiar Investors first reported a position in Eli Lilly in Q4 2016 and held it in 5 quarters.
  • Cambiar Investors's Eli Lilly position peaked at $46.3M in Q1 2017.
  • 1,333 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2018.

Based on Cambiar Investors's 13F filing for Q1 2018, filed 26 Apr 2018.